EICHOR
● Active Not Recruiting
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Condition: Short Bowel Syndrome (SBS) · Sponsor: Zealand Pharma
About this study
The purpose of this study is to understand the safety and efficacy of twice weekly glepaglutide 10 mg in adult patients with short bowel syndrome (SBS), who were previously enrolled in the EASE SBS 2 or EASE SBS 3 trials. Participants currently on these trials will be able to continue their glepaglutide treatment by enrolling in this EASE SBS 6 extension trial. The trial includes a 24-month treatment period, followed by a 4-week safety follow-up period. Participants will attend trial visits, where they may undergo heart tests (electrocardiogram (ECG)), vital sign checks, colonoscopies, blood and urine tests, and physical exams.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (16)
| Mayo Clinic - PPDS | Rochester, Minnesota, United States | — |
| Lied Transplant Center at Nebraska Medical Center | Omaha, Nebraska, United States | — |
| Cleveland Clinic-9500 Euclid Ave | Cleveland, Ohio, United States | — |
| Vanderbilt University Medical Center-Tennesse-1211 21st Ave S | Nashville, Tennessee, United States | — |
| UZ Leuven - PPDS | Leuven, Belgium | — |
| LHSC - University Hospital | London, Ontario, Canada | — |
| AP-HP - Hôpital Beaujon | Clichy, Hauts-de-Seine, France | — |
| Universitätsklinikum Frankfurt | Frankfurt am Main, Hesse, Germany | — |
| Universitätsmedizin Rostock | Rostock, Mecklenburg-Vorpommern, Germany | — |
| Universitätsklinikum Bonn | Bonn, North Rhine-Westphalia, Germany | — |
| Charité - Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | — |
| Asklepios Klinik St. Georg | Hamburg, Germany | — |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07228403